Hormone Classes and Biosynthesis

Endocrinologists classify hormones by chemical structure into three broad categories: peptide/protein hormones, steroid hormones, and amine hormones. Peptide hormones range from small chains of just three amino acids (thyrotropin-releasing hormone) to large glycoproteins of over 200 residues (follicle-stimulating hormone); they are built from strings of amino acids linked by peptide bonds, exactly like any other cellular protein, using the standard machinery of transcription, translation, and post-translational processing. Steroid hormones — cortisol, aldosterone, testosterone, estradiol, progesterone — are all derivatives of the four-ringed sterol cholesterol, and they are synthesized by a cascade of enzymatic modifications (mostly oxidations by cytochrome P450 enzymes) rather than by ribosomal assembly. Amine hormones are the smallest, derived from single amino acids — mostly tyrosine — and they split functionally into two very different subgroups: the catecholamines (epinephrine, norepinephrine, dopamine), which are water-soluble and behave biosynthetically like peptides, and the thyroid hormones (thyroxine, triiodothyronine), which are iodinated and lipophilic and behave biosynthetically like steroids. This classification is not academic trivia — it is the single most predictive fact about a hormone. Chemical class determines solubility, which determines whether the hormone can be stored inside the cell (water-soluble hormones can be packaged into aqueous vesicles; lipid-soluble hormones would simply diffuse through the vesicle membrane and cannot be stored in bulk). Solubility also determines transport in blood: hydrophilic peptides and catecholamines dissolve freely in plasma, while hydrophobic steroids and thyroid hormones must ride on carrier proteins to stay in solution. And solubility determines mechanism of action, foreshadowed here and developed fully in Hormone Receptors and Signal Transduction: water-soluble hormones cannot cross the lipid bilayer, so their receptors sit on the plasma membrane and trigger intracellular second-messenger cascades, while lipid-soluble hormones diffuse straight through the membrane to bind receptors inside the cytoplasm or nucleus and act directly on gene transcription. A useful organizing rule of thumb, always taught with the caveat that thyroid hormone is the exception that proves it: peptides and catecholamines are fast, stored, water-soluble, and act via surface receptors; steroids and thyroid hormones are slow, made-on-demand (or stored in the case of thyroid hormone, uniquely, extracellularly), lipid-soluble, and act via intracellular receptors.

Peptide and protein hormones: the secretory pathway

Peptide hormone synthesis follows the same route that any secreted or membrane protein takes through the cell, discovered largely through Günter Blobel's work on the signal hypothesis (Nobel Prize, 1999). 1. Gene transcription and translation of a preprohormone. The hormone's gene is transcribed into mRNA in the nucleus, which is translated on ribosomes. The very first stretch of amino acids made is a signal (or "leader") sequence, roughly 15–30 residues long, hydrophobic in character. 2. Co-translational entry into the rough ER. The signal sequence is recognized by a signal recognition particle (SRP), which halts translation and escorts the ribosome-mRNA complex to a receptor on the rough endoplasmic reticulum. Translation resumes, threading the growing peptide chain through a protein channel (translocon) directly into the ER lumen. Inside the ER, a signal peptidase cleaves off the signal sequence, leaving a prohormone. 3. Packaging and further cleavage in the Golgi. The prohormone moves via transport vesicles to the Golgi apparatus, where it is further trimmed by specific proteases (often prohormone convertases) into the final, biologically active hormone — sometimes yielding several distinct peptide products from one prohormone (for example, pro-opiomelanocortin, POMC, is cleaved into ACTH, β-endorphin, and melanocyte-stimulating hormones in different tissues). 4. Storage in secretory (chromaffin/zymogen-like) granules. The finished hormone is concentrated and packaged into membrane-bound secretory vesicles, which bud from the trans-Golgi network and are stored in the cytoplasm — sometimes for days — awaiting a stimulus. 5. Regulated exocytosis. An appropriate stimulus (typically a rise in intracellular Ca²⁺ following an action potential or receptor activation) triggers vesicle fusion with the plasma membrane and release of the hormone into the extracellular fluid, from which it diffuses into capillaries. Because peptide hormones are pre-made and stored, the endocrine cell can respond to a stimulus within seconds to minutes — the rate-limiting step is exocytosis, not synthesis. Once in blood, peptide hormones dissolve freely in the aqueous plasma (with a few exceptions, like growth hormone, which has partial binding proteins) and are cleared quickly, typically with plasma half-lives of only a few minutes, because they are small enough to be filtered by the kidney and are degraded rapidly by circulating and tissue peptidases.

Steroid hormones: synthesis on demand

Steroid-producing cells (adrenal cortex, gonads, placenta) do not stockpile finished hormone. Instead they store the precursor, cholesterol, as cholesteryl ester droplets, and synthesize the active steroid only when stimulated — a fundamentally different logic from the peptide "make now, release later" strategy. 1. Cholesterol mobilization. A tropic hormone (e.g., ACTH acting via cAMP) activates cholesteryl ester hydrolase, freeing cholesterol from stored lipid droplets, and up-regulates StAR (steroidogenic acute regulatory protein), which shuttles cholesterol across the outer mitochondrial membrane to the inner membrane — the rate-limiting step of steroidogenesis. 2. Side-chain cleavage. Inside the mitochondrion, the enzyme P450scc (cholesterol side-chain cleavage enzyme, CYP11A1) clips off part of the cholesterol side chain to form pregnenolone, the common precursor of all steroid hormones. 3. Sequential enzymatic modification, shuttling between mitochondria and smooth ER. Pregnenolone is exported to the smooth endoplasmic reticulum, where a series of cytochrome P450 and hydroxysteroid dehydrogenase enzymes (3β-HSD, 17α-hydroxylase, 21-hydroxylase, 11β-hydroxylase, aromatase, and others) convert it stepwise into the final product specific to that gland: cortisol and aldosterone in the adrenal cortex, testosterone in Leydig cells of the testis, estradiol and progesterone in the ovary. Which enzymes a given cell expresses determines which final steroid it makes — the "backbone" pathway is identical, but tissue-specific enzyme expression diverts the flux. 4. Immediate diffusion — no storage. Because steroids are lipid-soluble, as soon as they are made they diffuse straight across the cell membrane into the blood; there is no secretory vesicle to hold them. This means steroid output is regulated entirely at the level of synthesis rate, not release — a key mechanistic contrast with peptide hormones. 5. Carrier-protein transport in blood. Being hydrophobic, steroids cannot dissolve appreciably in aqueous plasma, so 95–98% of circulating cortisol is bound to corticosteroid-binding globulin (transcortin) and albumin; testosterone and estradiol are bound mainly to sex hormone-binding globulin (SHBG) and albumin. Only the small free fraction is biologically active and able to diffuse into target cells. Because carrier binding protects the hormone from rapid hepatic/renal clearance, steroid hormones have much longer plasma half-lives than peptides — cortisol's half-life is roughly 60–90 minutes, and thyroid hormone's is measured in days.

Amine hormones: two biosynthetic personalities

Both catecholamines and thyroid hormones are derived from the amino acid tyrosine, but their synthesis and behavior diverge sharply.

Catecholamines (in the adrenal medulla and sympathetic neurons) are synthesized by a short, four-enzyme cytoplasmic pathway: tyrosine → (tyrosine hydroxylase, rate-limiting) → L-DOPA → (DOPA decarboxylase) → dopamine → (dopamine β-hydroxylase, inside the vesicle) → norepinephrine → (phenylethanolamine-N-methyltransferase, PNMT, cytoplasmic, cortisol-dependent) → epinephrine. Like peptide hormones, catecholamines are water-soluble, are packaged and stored in chromaffin granules, and are released by calcium-triggered exocytosis upon sympathetic stimulation — their storage/release logic is functionally identical to a peptide hormone even though their chemical synthesis (enzymatic modification of a single amino acid) resembles steroidogenesis. They travel free in plasma and have a very short half-life of about 1–3 minutes.

Thyroid hormones are made by a genuinely unusual mechanism, unique in endocrinology: synthesis occurs extracellularly, within the colloid of the thyroid follicle. 1. Follicular cells synthesize and secrete thyroglobulin, a large glycoprotein, into the follicular lumen (colloid). 2. Iodide is actively transported into the follicular cell (the sodium-iodide symporter) and pumped into the colloid, where thyroid peroxidase oxidizes it and attaches iodine atoms to tyrosine residues still embedded in the thyroglobulin molecule, forming monoiodotyrosine (MIT) and diiodotyrosine (DIT). 3. Thyroid peroxidase then couples pairs of these iodinated tyrosines within the same thyroglobulin molecule: two DIT combine to form thyroxine (T4), and one MIT plus one DIT form triiodothyronine (T3). 4. The iodinated thyroglobulin is stored extracellularly in the colloid — the only hormone stored outside its parent cells — for weeks to months, providing a substantial reserve. 5. On stimulation by TSH, follicular cells endocytose colloid, lysosomal proteases cleave T4 and T3 free of thyroglobulin, and the small lipophilic hormones diffuse into the blood. 6. In blood, over 99.5% of T4 and T3 is bound to thyroxine-binding globulin (TBG), transthyretin, and albumin, giving T4 an unusually long plasma half-life of about 6–7 days.

Transport and half-life: why solubility is destiny

The final leg of a hormone's journey — travel through blood to a target tissue — is governed entirely by the same solubility property that determined its storage. Water-soluble hormones (peptides, catecholamines) dissolve directly in plasma; they are cleared quickly by enzymatic degradation and renal filtration, giving them half-lives of 1–10 minutes, well suited to rapid, moment-to-moment regulation (e.g., minute-to-minute control of blood glucose by insulin, or fight-or-flight bursts of epinephrine). Lipid-soluble hormones (steroids, thyroid hormones) cannot dissolve in plasma and must be chaperoned by carrier proteins; carrier binding protects them from clearance, giving them half-lives of hours (steroids) to days (thyroid hormones), suited to sustained, background regulation of metabolism, growth, and long-term stress adaptation. Only the small free (unbound) fraction of a carrier-bound hormone is biologically active — typically just 1–10% of total circulating steroid or thyroid hormone — because only free hormone is small and mobile enough to diffuse across the target cell membrane; this free-hormone concept becomes central when clinicians interpret "total" versus "free" T4 or cortisol levels.

The signal hypothesis (Blobel and colleagues, 1970s). How does a cell know that a given protein — but not others — should be threaded into the endoplasmic reticulum for eventual secretion, rather than staying free in the cytoplasm? Günter Blobel, building on earlier cell-fractionation work with George Palade (who had used pulse-chase radioactive labeling and electron-microscope autoradiography in the 1960s to trace secretory proteins from ribosome → ER → Golgi → secretory granule in pancreatic acinar cells), proposed that secreted proteins carry a short N-terminal "signal sequence" that targets them to the ER. Blobel and Blobel/Dobberstein tested this using cell-free translation systems: mRNA for a secretory protein (immunoglobulin light chain) was translated by ribosomes in vitro without microsomes (rough ER vesicles) present, and the resulting protein was slightly larger than the mature secreted form. When microsomes were added during translation, the protein was correctly processed to its mature, smaller size and ended up sequestered inside the vesicles, protected from added protease — direct proof that a cleavable signal sequence directs co-translational translocation into the ER lumen. This work, awarded the Nobel Prize in Physiology or Medicine in 1999, established the very first step of the peptide-hormone biosynthetic pathway described above and is now understood to be a general mechanism for essentially all secreted and membrane proteins, hormones included.

Radioimmunoassay and pulse-chase tracing of prohormone processing (Steiner, 1967). Donald Steiner's laboratory, studying insulin biosynthesis in pancreatic islet cells, pulse-labeled cells with radioactive amino acids and then chased over time, isolating labeled protein at successive intervals. He discovered a larger radioactive precursor molecule that appeared before mature insulin and could be chemically converted into insulin plus a residual peptide fragment — he named this precursor proinsulin, and the discarded fragment C-peptide. This directly demonstrated, for the first time, that a peptide hormone is synthesized as an inactive, larger prohormone and then proteolytically trimmed to its active form inside the secretory pathway — confirming step 3 of the peptide biosynthetic mechanism and establishing the general concept of prohormone processing that applies across the endocrine system (ACTH/POMC, glucagon, PTH, and many others).

Steroidogenesis and the cholesterol side-chain cleavage enzyme (mid-20th century biochemistry, e.g. work synthesized by Samuel Solomon and colleagues in the 1950s–60s). Using radiolabeled cholesterol (¹⁴C-cholesterol) perfused into isolated adrenal and gonadal tissue, biochemists tracked the appearance of radioactivity in pregnenolone and downstream steroids, establishing cholesterol as the universal steroid precursor and mapping the sequence of enzymatic conversions. Later purification of the mitochondrial cytochrome P450scc enzyme complex, and demonstration that adding purified P450scc to cholesterol in vitro generates pregnenolone, confirmed the specific enzymatic first step of steroidogenesis and explained why steroidogenic cells are packed with mitochondria and smooth ER rather than secretory granules — direct structural evidence, visible by electron microscopy, that these cells synthesize on demand rather than store.

Thyroid hormone's extracellular storage (autoradiographic studies, Jacques Dumont and others, 1960s–70s). Radioactive iodine (¹³¹I) injected into experimental animals was traced by autoradiography and shown to accumulate first inside follicular cells (confirming active iodide uptake by the sodium-iodide symporter), then rapidly appear in the follicular lumen (colloid) bound to thyroglobulin, where it could remain for weeks before slowly reappearing inside the cell during TSH-stimulated endocytosis and finally in blood. This traced, step by step, the uniquely extracellular storage mechanism of thyroid hormone synthesis and explained clinically why iodine deficiency or thyroid peroxidase blockade (e.g., by drugs like propylthiouracil) has a delayed effect on circulating hormone — there is a large extracellular reserve already stored in colloid.

Example 1 — Predicting route of administration and dosing interval from chemical class. A clinician must choose whether two new therapeutic molecules can be given as a once-daily pill or must be injected, and how often: Drug A is a 51-amino-acid polypeptide; Drug B is a lipophilic four-ring steroid derivative. Reasoning: Drug A, being a peptide, will be degraded by gastric and pancreatic proteases if swallowed, so it must be given by injection (subcutaneous or intravenous) — exactly why insulin (51 amino acids, two chains) cannot be taken orally. Because peptide hormones are cleared from plasma within minutes (no protective carrier protein), Drug A will likely require multiple daily injections or a slow-release depot formulation to maintain effective blood levels. Drug B, a steroid, survives digestion (it isn't a substrate for peptidases) and is absorbed intact across the gut lining because it is lipophilic — so it can be given as an oral pill, exactly as prednisone or oral contraceptives are. Because steroids bind plasma carrier proteins and are cleared slowly (hours), Drug B can likely be dosed once or twice daily rather than continuously infused. This single classification — peptide versus steroid — determines the entire pharmacokinetic strategy before a single clinical trial is run.

Example 2 — Free hormone calculation in thyroid disease. A patient's total serum T4 is measured at 120 nmol/L (within the normal total range of roughly 60–150 nmol/L), but the physician suspects abnormal thyroxine-binding globulin (TBG) levels, common in pregnancy or with oral estrogen use, which raise TBG and thus total T4 without changing the physiologically active free fraction. Normally, only about 0.03% of circulating T4 is free (unbound); the rest is bound to TBG, transthyretin, and albumin. Free T4 in this patient = 120 nmol/L × 0.0003 ≈ 0.036 nmol/L, which is within the normal free T4 range (roughly 0.010–0.025 nmol/L is typical, so this patient is mildly elevated) — but the key teaching point is the calculation logic, not the exact reference range, which varies by assay. If the patient is pregnant, estrogen increases hepatic synthesis of TBG, which increases total T4 (more binding sites, more bound hormone) while free T4, the biologically active fraction that a target cell can actually access, stays regulated near normal by the hypothalamic-pituitary-thyroid feedback axis (covered in Thyroid Hormones and Metabolic Rate). This example shows why clinicians order free T4, not total T4, to assess actual thyroid hormone action at the tissue level — a direct consequence of the carrier-protein transport mechanism unique to lipophilic hormones.

Understanding hormone class translates directly into modern medicine and biotechnology. Recombinant peptide hormone production — insulin, growth hormone, erythropoietin — depends entirely on knowing the preprohormone-to-prohormone-to-mature-hormone processing pathway; biotechnology exploits bacterial or yeast expression systems engineered to mimic (or bypass) this natural processing to mass-produce hormone identical to the human product, replacing hormone once purified painstakingly from animal pancreases or human cadaveric pituitaries (the latter practice was discontinued after it caused transmission of Creutzfeldt-Jakob disease via contaminated cadaveric growth hormone, a stark historical lesson in extraction-based hormone sourcing). Steroid biosynthesis enzymes are major drug targets: aromatase inhibitors (letrozole, anastrozole) block the conversion of testosterone to estradiol in breast cancer treatment; 5α-reductase inhibitors (finasteride) block conversion of testosterone to the more potent dihydrotestosterone for benign prostatic hyperplasia and hair loss; and congenital adrenal hyperplasia, a group of inherited enzyme deficiencies (most commonly 21-hydroxylase deficiency), is diagnosed and monitored by measuring accumulated steroid intermediates upstream of the missing enzyme. Carrier-protein pharmacokinetics guide dosing of oral contraceptives, corticosteroids, and thyroid hormone replacement (levothyroxine), and explain why levothyroxine, bound almost entirely to TBG, needs only once-daily dosing despite its rapid intracellular actions. Thyroid hormone biosynthesis is exploited diagnostically and therapeutically: radioactive iodine uptake scans exploit the sodium-iodide symporter to image or selectively destroy overactive thyroid tissue (Graves' disease, thyroid cancer), while antithyroid drugs like methimazole block thyroid peroxidase to slow hormone synthesis in hyperthyroidism. In agriculture, understanding steroid biosynthesis underlies the use (and regulation) of anabolic steroid growth promoters in livestock, and understanding peptide hormone stability underlies veterinary insulin and growth hormone formulations for managing diabetic pets and livestock growth. In conservation biology, measuring steroid hormone metabolites (which are stable enough to persist in feces) non-invasively in wildlife droppings allows researchers to monitor stress (cortisol) and reproductive status (progesterone, testosterone) in endangered populations without ever capturing the animal — a direct application of knowing that steroids and their metabolites are lipophilic, stable, and excreted in measurable quantities.

Ask the tutor: How does knowing a hormone's chemical class predict whether its receptor will be on the cell surface or inside the cell?